FirstWord Pharma’s Post

You wouldn’t give your mother or your friend a medicine that ‘might’ work – so why would you do the same with an app? I wrote a piece for Friends of Europe on what must happen for patients across the world to benefit from digital therapeutics. I'm convinced the answer is higher standards for suppliers. That might seem counterintuitive - higher standards & regulation don't often lead to rapid adoption. However, this approach is essential to avoid adoption for adoption’s sake. Higher adoption is only good news if the digital therapeutics we adopt benefit patients; clearer standards are fundamental to that.

❝Just as the pharmaceutical industry successfully scaled access to medicines, so too can the digital therapeutics industry scale access to psychological care to meet global needs.❞ Digital therapeutics have the potential to completely transform mental healthcare worldwide, and Europe is uniquely positioned to shape how they will be adopted. With this opportunity, however, comes a duty to healthcare providers and patients alike. Europe must lead the way by setting a high standard for what defines digital therapeutics and their implementation. In this new Critical Thinking article, Will Goddard, UK managing director Big Health, highlights the need for collaboration among European countries and defines the necessary parameters for regulation. ️⤵️ Read the full article below. #CriticalThinking #SustainableLivelihoods #DigitalHealth #MentalHealth 

Thoughts on this? >> Exclusive: Lilly backs a16z-funded Arda Therapeutics' $43M Series A to take ADCs into fibrosis >> Comment below! >>> lqventures.com #pharma #productmarketing #healthcare #biotech #pharmaceutical

Thoughts on this? >> Exclusive: Lilly backs a16z-funded Arda Therapeutics' $43M Series A to take ADCs into fibrosis >> Comment below! >>> lqventures.com #pharmaceutical #healthcare #productmarketing #biotech #pharma

What steps will you take to ensure your new, innovative radiopharmaceutical delivers on its clinical promise and achieves successful commercial adoption? We've got some suggestions. Tune in to Fractals: Life Science Conversations with guest Andrew Beck to unravel the mysteries of the radiopharmaceutical 'unk-unk', understand the significance of patient education in sales, and learn why an integrated approach is pivotal for effective strategy. https://lnkd.in/gmYgnpHa #Radiopharmaceuticals #CommercializationStrategy #LifeSci #Bracken

We will never have enough clinicians to meet the need for mental health services. We need scalable solutions that are proven to work. Europe is rapidly increasing access to digital treatments and other regions will soon follow. Our very own Will Goddard wrote a piece about how we can address mental health needs worldwide through our digital treatments. Worth a read. #mentalhealth #digitaltreatments

So many exciting new developments in this field and so much potential.

Thoughts on this? >> Precigen lays off staff, pauses multiple CAR-T programs and all preclinical work and aims for $30M offering >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #healthcare #pharma #pharmaceutical

Thoughts on this? >> Precigen lays off staff, pauses multiple CAR-T programs and all preclinical work and aims for $30M offering >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #healthcare #productmarketing

In this latest K-Cast series, “Advancing Healthcare With Prescription Drug Therapeutics,” Masha Salsabili, PharmD, PhD offers insights on the future of prescription digital therapeutics (PDTs) and how the landscape might evolve for PDTs over the next 5 years. Watch the series here: https://bit.ly/4dR4oLW #ManagedCare #HealthTech